会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 13. 发明授权
    • PODXL protein in colorectal cancer
    • PODXL蛋白在结肠直肠癌中的表达
    • US08999656B2
    • 2015-04-07
    • US13456354
    • 2012-04-26
    • Karin JirströmMathias UhlénFredrik Pontén
    • Karin JirströmMathias UhlénFredrik Pontén
    • G01N33/574C07K16/30
    • G01N33/57419C07K16/22C07K16/3046C07K2317/76G01N2333/705G01N2333/90216G01N2800/52G01N2800/56
    • The present disclosure provides a method for determining whether a mammalian subject having a colorectal cancer belongs to a first or a second group, wherein the prognosis of subjects of the first group is better than the prognosis of subjects of the second group, comprising the steps of: a) evaluating an amount of PODXL protein in at least part of a sample earlier obtained from the subject, and determining a sample value corresponding to the evaluated amount; b) comparing said sample value from step a) with a predetermined reference value; and if said sample value is higher than said reference value, c1) concluding that the subject belongs to said second group; and if said sample value is lower than or equal to said reference value, c2) concluding that the subject belongs to said first group. Related uses, means and a method of treatment are also provided.
    • 本公开提供了一种用于确定具有结肠直肠癌的哺乳动物受试者是否属于第一组或第二组的方法,其中第一组受试者的预后优于第二组受试者的预后,包括以下步骤: :a)评估早先从受试者获得的样品的至少一部分中的PODXL蛋白的量,并确定与评估量相对应的样品值; b)将来自步骤a)的所述样本值与预定参考值进行比较; 并且如果所述样本值高于所述参考值,则c1)认定所述对象属于所述第二组; 并且如果所述样本值小于或等于所述参考值,则c2)断定所述对象属于所述第一组。 还提供了相关用途,手段和治疗方法。